The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early Schizophrenia

被引：7

作者：

Horvitz-Lennon, Marcela ^{[1
]}

Predmore, Zachary ^{[1
,3
]}

Orr, Patrick ^{[1
,5
]}

Hanson, Mark ^{[2
,4
]}

Hillestad, Richard ^{[2
]}

Durkin, Mike ^{[6
]}

El Khoury, Antoine C. ^{[6
]}

Mattke, Soeren ^{[1
,4
]}

机构：

[1] RAND Corp, 20 Pk Plaza,Suite 920, Boston, MA 02116 USA

[2] RAND Corp, Santa Monica, CA USA

[3] Johns Hopkins Univ, Baltimore, MD USA

[4] Univ Southern Calif, Los Angeles, CA 90007 USA

[5] Informat Mapping, Boston, MA USA

[6] Janssen Sci Affairs LLC, Titusville, NJ USA

来源：

ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH | 2020年 / 47卷 / 03期

关键词：

Schizophrenia; Treatment adherence; Early detection; Simulation; QUALITY-OF-LIFE; UNTREATED PSYCHOSIS; 1ST-EPISODE SCHIZOPHRENIA; EARLY INTERVENTION; NEGATIVE SYMPTOMS; MENTAL-ILLNESS; UNITED-STATES; DURATION; DISORDERS; PEOPLE;

D O I：

10.1007/s10488-019-00990-7

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The impact of initiatives aimed at reducing time in untreated psychosis during early-stage schizophrenia will be unknown for many years. Thus, we simulate the effect of earlier treatment entry and better antipsychotic drug adherence on schizophrenia-related hospitalizations, receipt of disability benefits, competitive employment, and independent/family living over a ten-year horizon. We predict that earlier treatment entry reduces hospitalizations by 12.6-14.4% and benefit receipt by 7.0-8.5%, while increasing independent/family living by 41.5-46% and employment by 42-58%. We predict larger gains if a pro-adherence intervention is also used. Our findings suggest substantial benefits of timely and consistent early schizophrenia care.

引用

页码：357 / 365

页数：9

共 50 条

[1] The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early Schizophrenia
Marcela Horvitz-Lennon
Zachary Predmore
Patrick Orr
Mark Hanson
Richard Hillestad
Mike Durkin
Antoine C. El Khoury
Soeren Mattke
Administration and Policy in Mental Health and Mental Health Services Research, 2020, 47 : 357 - 365
[2] THE LONG-TERM BENEFITS OF ENSURING TIMELY TREATMENT AND IMPROVED MEDICATION ADHERENCE IN EARLY SCHIZOPHRENIA: A MICROSIMULATION STUDY
Horvitz-Lennon, M.
Predmore, Z.
Orr, P.
Hanson, M.
Hillestad, R.
Durkin, M.
El Khoury, A. C.
Mattke, S.
VALUE IN HEALTH, 2018, 21 : S188 - S189
[3] The role of adherence to medication in the effectiveness of long-term treatment of schizophrenia
Volavka, J.
Lindenmayer, J. P.
Liu-Seifert, H.
Kulkarni, P.
Kinon, B. J.
Stauffer, V.
Edwards, B.
Chen, L.
Adams, D. H.
Buckley, P. F.
Citrome, L.
EUROPEAN PSYCHIATRY, 2007, 22 : S54 - S55
[4] Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care
Ascher-Svanum, H
Faries, DE
Zhu, BJ
Ernst, FR
Swartz, MS
Swanson, JW
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (03) : 453 - 460
[5] Long-term cardiovascular benefits predicted by early cholesterol reduction
不详
FUTURE LIPIDOLOGY, 2007, 2 (03): : 261 - 261
[6] Long-term medication in schizophrenia
Gaebel, W
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2000, 68 : S26 - S31
[7] LONG-TERM MEDICATION IN SCHIZOPHRENIA
PIETZCKER, A
NERVENARZT, 1978, 49 (09): : 518 - 533
[8] Strategies of long-term medication in schizophrenia
Gaebel, W
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2001, 69 : S113 - S119
[9] Investigation of medication adherence and reasons for poor adherence in patients on long-term glaucoma treatment regimes
McClelland, Julie F.
Bodle, Lynne
Little, Julie-Anne
PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 431 - 439
[10] LONG-TERM TREATMENT OF SCHIZOPHRENIA
HUBER, G
MEDIZINISCHE KLINIK, 1983, 78 (20) : 604 - 611

← 1 2 3 4 5 →